LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Dyne Therapeutics (NASDAQ: DYN)

Follow NASDAQ:DYN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ DYN Dyne Therapeutics
Friedl-Naderer Johanna / officer: Chief Commercial Officer
07/16/2025
Buy
$9.33
51,255
$478K
51,255
NASDAQ DYN Dyne Therapeutics
Kerr Douglas / officer: Chief Medical Officer
07/16/2025
Buy
$9.33
65,110
$607K
65,110
NASDAQ DYN Dyne Therapeutics
Cox John / director, officer: CEO & President
07/16/2025
Buy
$9.33
197,285
$1.841M
197,285
NASDAQ DYN Dyne Therapeutics
Cox John / director, officer: CEO & President
07/14/2025
Buy
$9.11
100,000
$911K
242,179

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous